| Frank V Thomas, MD | |
|
121 St. Lukes Center Drive, Suite 502, Chesterfield, MO 63017-3509 | |
| (314) 275-7800 | |
| (314) 275-7801 |
| Full Name | Frank V Thomas |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 29 Years |
| Location | 121 St. Lukes Center Drive, Chesterfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295796381 | NPI | - | NPPES |
| P00698741 | Other | MO | RAILROAD MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2004010786 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Home Health Services | Chesterfield, MO | Home health agency |
| St Lukes Hospital | Chesterfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Orthopedics And Sports Medicine Pc | 3577626282 | 3 |
News Archive
A new research discovery published online in the FASEB Journal (http://www.fasebj.org) may change the perception and treatment of diabetes. That's because scientists have moved closer toward correcting the root cause of the disease rather than managing its symptoms. Specifically researchers identified a protein (G6PD protein) and its antioxidant product (NAPDH) that both prevent the death and promote the growth of cells which produce and release insulin in the pancreas (beta cells).
Health Canada is reminding healthcare professionals, caregivers and consumers of the safe use of topical antiseptics used to clean the skin before an operation (preoperative) or before an injection (preinjection).
For more than 40 years, physicians have treated diminished kidney function as two distinct syndromes: acute kidney injury (AKI) and chronic kidney disease (CKD). However, recent epidemiologic and mechanistic studies suggest the two syndromes are not distinct entities, but interconnected.
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), is presenting a poster today on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer's Disease (ICAD 2010).
Synta Pharmaceuticals Corp. today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms' tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.
› Verified 1 days ago
| Entity Name | Central Orthopedics And Sports Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588827224 PECOS PAC ID: 3577626282 Enrollment ID: O20090107000130 |
News Archive
A new research discovery published online in the FASEB Journal (http://www.fasebj.org) may change the perception and treatment of diabetes. That's because scientists have moved closer toward correcting the root cause of the disease rather than managing its symptoms. Specifically researchers identified a protein (G6PD protein) and its antioxidant product (NAPDH) that both prevent the death and promote the growth of cells which produce and release insulin in the pancreas (beta cells).
Health Canada is reminding healthcare professionals, caregivers and consumers of the safe use of topical antiseptics used to clean the skin before an operation (preoperative) or before an injection (preinjection).
For more than 40 years, physicians have treated diminished kidney function as two distinct syndromes: acute kidney injury (AKI) and chronic kidney disease (CKD). However, recent epidemiologic and mechanistic studies suggest the two syndromes are not distinct entities, but interconnected.
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), is presenting a poster today on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer's Disease (ICAD 2010).
Synta Pharmaceuticals Corp. today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms' tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.
› Verified 1 days ago
| Entity Name | Urgent Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255820510 PECOS PAC ID: 4486995800 Enrollment ID: O20190412001473 |
News Archive
A new research discovery published online in the FASEB Journal (http://www.fasebj.org) may change the perception and treatment of diabetes. That's because scientists have moved closer toward correcting the root cause of the disease rather than managing its symptoms. Specifically researchers identified a protein (G6PD protein) and its antioxidant product (NAPDH) that both prevent the death and promote the growth of cells which produce and release insulin in the pancreas (beta cells).
Health Canada is reminding healthcare professionals, caregivers and consumers of the safe use of topical antiseptics used to clean the skin before an operation (preoperative) or before an injection (preinjection).
For more than 40 years, physicians have treated diminished kidney function as two distinct syndromes: acute kidney injury (AKI) and chronic kidney disease (CKD). However, recent epidemiologic and mechanistic studies suggest the two syndromes are not distinct entities, but interconnected.
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), is presenting a poster today on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer's Disease (ICAD 2010).
Synta Pharmaceuticals Corp. today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms' tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frank V Thomas, MD 121 Saint Lukes Center Dr, Suite 502, Chesterfield, MO 63017-3509 Ph: (314) 275-7800 | Frank V Thomas, MD 121 St. Lukes Center Drive, Suite 502, Chesterfield, MO 63017-3509 Ph: (314) 275-7800 |
News Archive
A new research discovery published online in the FASEB Journal (http://www.fasebj.org) may change the perception and treatment of diabetes. That's because scientists have moved closer toward correcting the root cause of the disease rather than managing its symptoms. Specifically researchers identified a protein (G6PD protein) and its antioxidant product (NAPDH) that both prevent the death and promote the growth of cells which produce and release insulin in the pancreas (beta cells).
Health Canada is reminding healthcare professionals, caregivers and consumers of the safe use of topical antiseptics used to clean the skin before an operation (preoperative) or before an injection (preinjection).
For more than 40 years, physicians have treated diminished kidney function as two distinct syndromes: acute kidney injury (AKI) and chronic kidney disease (CKD). However, recent epidemiologic and mechanistic studies suggest the two syndromes are not distinct entities, but interconnected.
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), is presenting a poster today on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer's Disease (ICAD 2010).
Synta Pharmaceuticals Corp. today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms' tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.
› Verified 1 days ago
Dr. Brian Wegman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 224 S Woods Mill Rd Ste 330s, Chesterfield, MO 63017 Phone: 314-576-7013 Fax: 314-576-4047 | |
Luke S Choi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14285 N. Outer Forty Rd, Suite 200, Chesterfield, MO 63195 Phone: 314-392-5060 | |
Dr. Laura Leigh Meyers, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 13001 N Outer 40 Rd, Dept Orthopaedic Surgery, Ste 1c, Chesterfield, MO 63017 Phone: 314-454-3013 Fax: 314-454-3034 | |
Benjamin P Crane, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14825 North Outer 40 Road, Suite 200, Chesterfield, MO 63017 Phone: 314-336-2555 Fax: 314-336-2557 | |
Timothy G Lang, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 224 S Woods Mill Rd Ste 330s, Chesterfield, MO 63017 Phone: 314-576-7013 Fax: 314-576-4047 | |
Dr. David M Brown, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 14825 N Outer 40 Rd, Suite 2005, Chesterfield, MO 63017 Phone: 314-336-2555 Fax: 314-336-2557 |